Stay updated on Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page displays the completed NCT02500121 study record for a phase II trial of maintenance pembrolizumab versus placebo in metastatic urothelial cancer, including study details and posted outcomes.
    Difference
    69%
    Check dated 2026-11-08T14:58:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible on a 403 error page.
    Difference
    0.2%
    Check dated 2026-11-01T16:02:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A banner announces an NIH website terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:52:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.2 instead of v3.7.1. The study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:32:15.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:20:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details and navigation with an access-denied message. This indicates the site is blocking access to the record.
    Difference
    19%
    Check dated 2026-09-20T22:49:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.